Sigma-Aldrich Initiates RNAi Partnership Program


Sigma-Aldrich has announced the establishment of a worldwide RNAi Partnership Program with select academic institutions to advance functional genomics research. Scientists from participating organizations will benefit from unique access to a broad portfolio of intellectual property, early access to emerging new technologies, and special partnership pricing on Sigma's cutting-edge range of functional genomics and RNAi products.

As part of the program, researchers at participating institutions will have early access to new technologies that are developed through Sigma- Aldrich's collaborations with TRC, Oxford BioMedica and Benitec. The partnership program will also facilitate collaborations with scientists at Sigma-Aldrich to validate current and emerging RNAi technologies.

Program participants will also benefit from a dedicated support team on Sigma's functional genomics product portfolio. This extensive product offering includes the Lentivirus-based MISSION(TM) TRC shRNA libraries, targeting more than 15,000 human and mouse genes, activated lentiviral particles, custom siRNA, and qPCR reagents.

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics